These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28646094)

  • 1. Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model.
    Levander S; Holmström F; Frelin L; Ahlén G; Rupp D; Long G; Bartenschlager R; Sällberg M
    Gut; 2018 Aug; 67(8):1525-1535. PubMed ID: 28646094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene.
    Frelin L; Ahlén G; Alheim M; Weiland O; Barnfield C; Liljeström P; Sällberg M
    Gene Ther; 2004 Mar; 11(6):522-33. PubMed ID: 14999224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Combination Vaccine, Comprising Bifidobacterium Displaying Hepatitis C Virus Nonstructural Protein 3 and Interferon-α, Induces Strong Cellular Immunity Specific to Nonstructural Protein 3 in Mice.
    Kitagawa K; Omoto C; Oda T; Araki A; Saito H; Shigemura K; Katayama T; Hotta H; Shirakawa T
    Viral Immunol; 2017 Apr; 30(3):196-203. PubMed ID: 28112593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Levander S; Sällberg M; Ahlén G; Frelin L
    Vaccine; 2016 May; 34(25):2821-33. PubMed ID: 27109565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
    Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
    Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous T cells can help restore function in dysfunctional hepatitis C virus nonstructural 3/4A-specific T cells during therapeutic vaccination.
    Chen A; Ahlén G; Brenndörfer ED; Brass A; Holmström F; Chen M; Söderholm J; Milich DR; Frelin L; Sällberg M
    J Immunol; 2011 May; 186(9):5107-18. PubMed ID: 21430225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo clearance of hepatitis C virus nonstructural 3/4A-expressing hepatocytes by DNA vaccine-primed cytotoxic T lymphocytes.
    Ahlen G; Nystrom J; Pult I; Frelin L; Hultgren C; Sallberg M
    J Infect Dis; 2005 Dec; 192(12):2112-6. PubMed ID: 16288375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).
    Seiwert SD; Andrews SW; Jiang Y; Serebryany V; Tan H; Kossen K; Rajagopalan PT; Misialek S; Stevens SK; Stoycheva A; Hong J; Lim SR; Qin X; Rieger R; Condroski KR; Zhang H; Do MG; Lemieux C; Hingorani GP; Hartley DP; Josey JA; Pan L; Beigelman L; Blatt LM
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4432-41. PubMed ID: 18824605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
    Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus NS3-4A protease regulates the lipid environment for RNA replication by cleaving host enzyme 24-dehydrocholesterol reductase.
    Tallorin L; Villareal VA; Hsia CY; Rodgers MA; Burri DJ; Pfeil MP; Llopis PM; Lindenbach BD; Yang PL
    J Biol Chem; 2020 Aug; 295(35):12426-12436. PubMed ID: 32641492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.
    Frelin L; Brenndörfer ED; Ahlén G; Weiland M; Hultgren C; Alheim M; Glaumann H; Rozell B; Milich DR; Bode JG; Sällberg M
    Gut; 2006 Oct; 55(10):1475-83. PubMed ID: 16527836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities.
    Ratnoglik SL; Jiang DP; Aoki C; Sudarmono P; Shoji I; Deng L; Hotta H
    PLoS One; 2014; 9(6):e98877. PubMed ID: 24901478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens.
    Young KG; Haq K; MacLean S; Dudani R; Elahi SM; Gilbert R; Weeratna RD; Krishnan L
    J Viral Hepat; 2018 Jun; 25(6):649-660. PubMed ID: 29316037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term functional duration of immune responses to HCV NS3/4A induced by DNA vaccination.
    Ahlén G; Holmström F; Gibbs A; Alheim M; Frelin L
    Gene Ther; 2014 Aug; 21(8):739-50. PubMed ID: 24871581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Replication of the subgenomic hepatitis C virus replicon in the presence of the NS3 protease inhibitors: a stochastic model].
    Ivanisenko NV; Mishchenko EL; Akberdin IR; Demenkov PS; Likhoshvai VA; Kozlov KN; Todorov DI; Samsonova MG; Samsonov AM; Kolchanov NA; Ivanisenko VA
    Biofizika; 2013; 58(5):758-74. PubMed ID: 25481944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity and protection by adoptive transfer of dendritic cells transfected with hepatitis C NS3/4A mRNA.
    Yu H; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Feb; 25(10):1701-11. PubMed ID: 17240490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission.
    Anggakusuma ; Brown RJP; Banda DH; Todt D; Vieyres G; Steinmann E; Pietschmann T
    J Virol; 2016 Dec; 90(23):10670-10681. PubMed ID: 27654291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase.
    Lam AM; Frick DN
    J Virol; 2006 Jan; 80(1):404-11. PubMed ID: 16352565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C Virus NS3 Protein Plays a Dual Role in WRN-Mediated Repair of Nonhomologous End Joining.
    Chen TI; Hsu YK; Chou CY; Chen YH; Hsu ST; Liou YS; Dai YC; Chang MF; Chang SC
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.